WW International (NASDAQ:WW – Get Free Report) announced its quarterly earnings data on Thursday. The company reported ($5.20) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.85) by ($4.35), FiscalAI reports. The firm had revenue of $168.26 million during the quarter, compared to the consensus estimate of $149.80 million.
Here are the key takeaways from WW International’s conference call:
- Clinical (Med+) momentum — end-of-period clinical subscribers reached 197,000 (51% sequential growth) and clinical subscription revenue rose 32% year?over?year; clinical ARPU remains >4x behavioral and management expects clinical to be ~25–30% of 2026 revenue.
- Behavioral subscriber base continues to shrink — end-of-period behavioral subscribers were 2.5 million, down 25% year?over?year, contributing to Q1 revenue of $168 million, a 10% decline versus prior year.
- Company reaffirmed 2026 guidance (revenue $620–$635M; adjusted EBITDA $105–$115M), expects to generate cash in 2026, and will use $37 million in Q2 to reduce term?loan principal, cutting ~$4 million of annual interest.
- Strategic positioning around GLP?1s — management highlighted that combining FDA?approved medications with WW behavioral support drives stronger outcomes (Med+ members in GLP?1 Success lost 29.1% more body weight at 12 months) and sees orals/affordability expanding the addressable market.
- Margins and spending are mixed — Q1 adjusted gross margin stayed near a record at 73.6% despite a clinical mix shift, but marketing was front?loaded at $93M and management expects modest gross?margin pressure in 2026 while marketing as a percent of revenue increases slightly.
WW International Stock Performance
Shares of NASDAQ WW opened at $10.20 on Friday. WW International has a fifty-two week low of $8.36 and a fifty-two week high of $46.95. The stock has a market cap of $101.99 million, a price-to-earnings ratio of -1.76 and a beta of 1.30. The firm’s 50-day simple moving average is $15.33 and its 200 day simple moving average is $22.64.
Wall Street Analyst Weigh In
Check Out Our Latest Analysis on WW
Institutional Investors Weigh In On WW International
A number of hedge funds have recently made changes to their positions in the business. Ameriprise Financial Inc. bought a new stake in shares of WW International in the 3rd quarter worth approximately $623,000. Quinn Opportunity Partners LLC purchased a new stake in WW International during the fourth quarter valued at about $1,010,000. Marshall Wace LLP purchased a new stake in WW International during the fourth quarter valued at about $1,108,000. Geode Capital Management LLC lifted its holdings in WW International by 3.9% during the fourth quarter. Geode Capital Management LLC now owns 113,610 shares of the company’s stock valued at $3,321,000 after purchasing an additional 4,251 shares during the last quarter. Finally, Cooper Creek Partners Management LLC purchased a new stake in WW International during the third quarter valued at about $3,336,000. 86.18% of the stock is currently owned by institutional investors.
WW International Company Profile
WW International, Inc (NASDAQ: WW) is a global wellness and weight management company that provides a range of subscription-based programs, digital tools and personalized coaching services. Originally founded in 1963 by Jean Nidetch as a small support group in New York City, the company grew into the well-known Weight Watchers brand before rebranding as WW in 2018 to reflect an expanded focus on overall health, fitness and nutrition. Over the years, WW has introduced innovations such as the SmartPoints® system, which assigns values to foods based on their nutritional composition, and the MyWW® personalized wellness plan, which tailors recommendations to individual lifestyles and goals.
WW’s offerings span digital and in-person channels.
Read More
Receive News & Ratings for WW International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WW International and related companies with MarketBeat.com's FREE daily email newsletter.
